As Ventana Board Rejects Takeover Bid, Roche Challenges Arizona Law, 'Poison Pill' Defense | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Roche has filed two lawsuits aimed at overturning an Arizona law and invalidating a “poison pill” defense that could delay or block its hostile bid to acquire Ventana Medical Systems for $3 billion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.